Why the decision to consider replacement is not failure

For many people, the months before a hip replacement assessment look the same: a course of physiotherapy, a trial of anti-inflammatories, perhaps an injection, and a quiet hope that the joint will settle. That instinct — to try everything reasonable before considering surgery — is not wrong. Conservative management is the correct starting point for hip osteoarthritis, and for a proportion of patients it provides enough relief to preserve quality of life for years.

But conservative care has defined limits. Its purpose is to exhaust the alternatives that genuinely work, not to postpone a well-evidenced intervention indefinitely. When pain persists through treatment, disrupts sleep, and begins to narrow what a person can do each day, continuing along the same path carries its own cost — in function lost, in muscle strength that quietly declines, and in the quality of life that erodes while a decision is deferred.

Hip replacement is not a last resort reserved for the most desperate cases. In England, Wales and Northern Ireland alone, more than 110,000 procedures were performed in a single year (National Joint Registry, 2019), making it one of the most frequently performed and rigorously studied orthopaedic operations in existence. For the right patient, at the right clinical moment, it is a timely and appropriate choice — not a concession.

The four clinical signals that mark the shift

Clinicians assessing whether conservative management has reached its limit tend to look at four overlapping signals rather than a single test or score. No single marker makes the decision; it is the severity and combination that carry the weight.

Night pain and pain at rest

Pain that arrives when you move is the hip warning that something is wrong. Pain that stays when you stop — waking you at 3 a.m. or persisting in a chair — is a different clinical signal entirely. Rest pain indicates the joint is inflamed beyond what activity can explain, and it is treated as a qualitatively stronger trigger for surgical assessment than discomfort that settles with stillness.

Functional decline that persists after physiotherapy

The practical test is straightforward: can you walk for more than roughly 15 minutes on a level surface, manage a flight of stairs, pull on a sock, or get in and out of a car without significant difficulty? If these basic daily tasks have become unreliable — and remain so after a genuine, structured course of physiotherapy — the conservative pathway has reached a natural limit. Physiotherapy can strengthen the muscles around a compromised joint; it cannot rebuild the joint surface.

Escalating reliance on medication or injections

Anti-inflammatories taken daily, or steroid injections repeated every few months simply to get through ordinary days, suggest the underlying disease is outpacing the treatment. The medication has not resolved the problem; it has been masking it. That distinction matters when reviewing whether the next clinical conversation should be about dosing or about replacement assessment.

Structural changes confirmed on imaging

X-ray findings of severe cartilage loss and bone-on-bone contact close the loop. They confirm that the joint has changed structurally in ways that no injection, exercise programme, or medication can reverse. When imaging corroborates what symptoms have already been signalling, the evidence for a surgical assessment becomes considerably harder to set aside.

How long is long enough: the three-month benchmark

The question of how long to persist with non-operative treatment has a practical answer. Before a surgical assessment becomes the next appropriate conversation, a structured programme — physiotherapy, analgesic optimisation, and where relevant, weight management — should have had sufficient time to demonstrate whether it is working. Clinically, that period is around three months. Not as a rigid rule, but as a reasonable point at which to take stock honestly: has the treatment produced meaningful, sustained improvement, or has it merely managed discomfort without changing the underlying trajectory?

The honest answer to that question matters more than the duration itself. NHS guidance is clear that symptoms not improving after at least three months of non-operative treatment represent a key threshold before replacement assessment is considered. If a structured programme over that period has not delivered improvement that is holding, continuing along the same path is unlikely to change the pattern.

What does change, however, is the surgical landscape — and this is where the logic of 'later is safer' begins to break down. Prolonged deferral in the presence of ongoing functional decline gradually weakens the muscles that support the hip and may affect the quality of bone into which an implant eventually needs to be secured. These are not catastrophic risks, but they are real clinical considerations that complicate eventual surgery. The relevant question is not whether you have tried hard enough; it is whether the treatment you are pursuing remains capable of delivering results that are actually holding.

Pain's effect on sleep, mood, and daily life

Sleep is where hip pain often does its most corrosive work. A joint that aches through the night does not simply interrupt rest — it accumulates a physiological debt that compounds fatigue, shortens patience, and narrows the mental resources available for everything else. Over weeks and months, this toll extends well beyond the hip.

Clinical assessment of whether conservative management is working takes this into account. Reduced participation in everyday life — withdrawing from social plans, giving up activities that brought routine satisfaction, scaling back at work — and its effect on mood are recognised factors in the surgical decision framework, not soft concerns to be noted and set aside. A patient who is adequately managing their pain score but can no longer walk to the shops, sit comfortably through a meal with friends, or pick up a grandchild has not achieved a satisfactory outcome from treatment.

The distinction is important. Surgical assessment is not triggered solely by how much pain a patient can endure. It is prompted, in part, by whether the treatment in place is preserving a life that is functional and engaged — or merely a life that is managed. When restricted mobility begins to affect mental wellbeing, that experience is formally part of the clinical picture. Conservative management cannot be judged on pain scores alone; functional restriction and its psychological consequences are documented considerations in the assessment, not subjective add-ons that a clinician might choose to discount.

The timing question for younger and more active patients

Age changes the texture of the replacement conversation without changing the underlying clinical logic.

Patients in their 40s and 50s who reach the threshold signals described earlier — night pain, functional failure, structural deterioration on imaging — face a genuinely more complicated calculation than older patients do. Modern implants, when correctly indicated and performed, may last well over 25 years; some data suggest around 58% last 25 years, and for the right patient, 30 years or more is plausible. Population-level averages, however, remain closer to 15–20 years. For a 47-year-old, that arithmetic matters: a single revision surgery is a realistic prospect, and revision procedures carry greater complexity than primary replacements.

For selected patients at this stage, bridging options can offer a measured period of symptom relief. Gel injections (hyaluronic acid, which lubricates the joint) and micro-fragmented fat injections — a different category from steroid injections, using the patient's own tissue to provide an anti-inflammatory biological effect rather than a corticosteroid — may reduce discomfort and help defer surgery for months or, in some cases, longer. Unlike steroids, these approaches are not primarily intended to damp down inflammation quickly; they aim to support the joint environment over a longer window. But they cannot restore lost cartilage or reverse structural deterioration, and their benefits are time-limited. For most patients, they represent a bridge, not a destination.

The signals from earlier in the article apply regardless of age. What age modifies is when surgery becomes the proportionate next step — and that judgement depends on activity level, rate of deterioration, and what further delay is likely to mean for surgical complexity and recovery. These are not decisions that resolve cleanly from a checklist, which is where individual specialist assessment becomes essential.

What a specialist assessment at this stage actually involves

The accumulated evidence from previous months — imaging reports, physiotherapy records, and a patient's own account of what daily life has become — arrives at a specialist appointment as raw material, not a verdict. What the consultation adds is interpretive: a clinician who can read that combination against a clinical framework and help the patient understand whether the pattern of findings has crossed the threshold that makes replacement the proportionate next step.

A specialist hip assessment draws on several strands simultaneously. Symptom history — specifically what triggers pain at rest and what no longer brings relief — sits alongside functional examination: whether range of motion has narrowed measurably under load, whether a limp has become habitual. Plain X-ray imaging adds the structural dimension, confirming whether severe joint space loss or bone-on-bone contact is present. Together, these strands build a picture that a pain score alone cannot capture.

The surgeon's role at this point is not simply to confirm or deny surgery. Not every patient presenting with night pain and restricted movement will need an operation within months; some remain appropriate for bridging measures. Others will have reached a clinical picture where further delay adds complexity without adding benefit. Getting that distinction right — for each patient, at each specific moment in their disease — is where specialist judgement carries most weight.

Professor Paul Lee, a Consultant Orthopaedic Surgeon at the Royal London Hospital and in private practice at 108 Harley Street, works specifically at this intersection: assessing the full clinical picture before committing to a surgical course, and treating the question of timing as seriously as technique. His SPAIRE muscle-sparing approach preserves the posterior tendons of the hip during replacement, reducing dislocation risk and supporting earlier, more confident mobilisation. Within this pathway, same-day or next-day discharge is possible for selected patients.

For someone who recognises the pattern this article has traced, the specialist assessment answers a specific question: not whether hip replacement is a known option, but whether this joint, at this point in its deterioration, has reached the moment where surgery is likely to return more than it costs.

1. [1] Hip Replacement — NHS. https://www.nhs.uk/conditions/hip-replacement/ https://www.nhs.uk/conditions/hip-replacement/